Medical Icons

Our Global Portfolio for Cardiovascular Health

About Amarin
Company Profile

A Global Leader in Cardiovascular Disease

Amarin is a global pharmaceutical company, focused on addressing cardiovascular health. We apply science, passion, and our global resources to support our BOLD vision to stop cardiovascular disease from being a leading cause of death worldwide and to significantly improve lives.

Amarin at a Glance

Amarin focuses on cardiovascular health on a global scale. Redefining the cardiovascular industry, Amarin boasts a skillful team of passionate employees and leaders – all BOLDLY working toward our vision. 

test

Total revenue earned

test

Patients treated

15+

Countries where we are

Setting a BOLD Vision into Action

Amarin is setting our BOLD vision into action by providing millions of people worldwide with a cardiovascular disease treatment with proven results. Our products are marketed by Amarin's commercial team and/or sold through commercial partners in numerous key markets throughout the world, with submissions seeking approval of our prescription drug under regulatory reviews in many other countries around the world.

Our vision

Rethinking Cardiovascular Care. Reducing Cardiovascular Risk.

LEARN MORE

BOLD Leadership

There are numerous traits that make great business leaders, such as being able to encourage others and having a clear vision that others can believe in. At Amarin, we also believe that long-term success can only be achieved through excellent leadership – like our fearlessly BOLD team of executive leaders. 

Company
Overview

Find out more about what Amarin does, how we do it and why we’re a global leader in the fight against cardiovascular disease.

  

Boardroom Meeting

Leadership

   


With decades of expertise in the cardiometabolic & pharma industry, we're committed to Amarin’s BOLD mission.

Partnering Shaking Hands

Partnering

    


Amarin partners with organizations globally to bring innovation and quality to our patients around the world.

ALL-NP-00015 1/23